Providing market intelligence for more than 35 years

In The News

The Apple Watch Is Scaling Back Its Health Features

The decision may have been made to avoid regulation by the FDA, according to BuzzFeed.

"Advanced biotracking sensors would have made the Apple Watch less of a multipurpose consumer device and more of a medical device used to diagnose diseases or track chronic conditions — which could have opened the watch up to regulation by the U.S. Food and Drug Administration.

'I don’t think Apple wants to be a health-monitoring device maker,' said Harry Wang, director of health and mobile product research at Parks Associates. 'They do want to leverage their popularity on the iPhone as a device platform, integrating all health data that can be collected for different devices.'" 

From the article "The Apple Watch Is Scaling Back Its Health Features" by Ian Servantes.

Previously In The News

Netflix Is Killing It—Big Time—After Pouring Cash Into Original Shows

“There seemed to be an attitude around the industry that after House of Cards and Orange is the New Black, there was no way Netflix could catch lightning in a bottle again,” says Glenn Hower, a senior...

The Simple Reason Why I Won't Buy Roku Inc.

Roku (NASDAQ:ROKU) went public on Sep. 28, its stock surging nearly 70% from its IPO price of $14 per share. The stock hit almost $30 the following day, but subsequently pulled back to the low $20s....

Bulls vs. Bears: Who's Right About Roku Stock?

Roku faces myriad competitors, but it still dominated the U.S. streaming device market with a 37% share as of early 2018, according to Parks Associates. Amazon ranked second with a 28% share, and Appl...

Roku Stock Jumps After a Blowout Holiday Quarter

The Roku Channel is also turning heads. The company's ad-supported channel was named one of the three best ad-based over-the-top services among U.S. broadband households according to Parks Associates,...